RAPT Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - RAPT Therapeutics, Inc. is set to present a company overview at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, highlighting its focus on immunology-based therapies for inflammatory and immunological diseases [1]. Company Overview - RAPT Therapeutics is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing novel therapies aimed at patients with inflammatory and immunological diseases [3]. - The company leverages its proprietary expertise in immunology to create therapies that modulate critical immune responses associated with these diseases [3]. Presentation Details - The presentation will be conducted by Brian Wong, M.D., Ph.D., who serves as the President and Chief Executive Officer of RAPT Therapeutics [1]. - The live webcast and archived recording of the presentation will be accessible through the RAPT Therapeutics website [2].